[1]
“Clinical Evaluation of APRI as a Non-Invasive Screening Tool for Liver Fibrosis and Cirrhosis in Faisalabad, Punjab, Pakistan”, Pjmcr, vol. 5, no. 2, pp. 4664–4673, Jun. 2026, doi: 10.66021/pakmcr1347.